Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Jun;83(6):528-35.
doi: 10.1007/s00104-011-2193-6.

[German adrenocortical carcinoma registry. Surgical therapy results and follow-up treatment]

[Article in German]
Affiliations
Review

[German adrenocortical carcinoma registry. Surgical therapy results and follow-up treatment]

[Article in German]
J Reibetanz et al. Chirurg. 2012 Jun.

Abstract

Adrenocortical carcinoma (ACC) is a highly aggressive endocrine disease with an incidence of 1-2 cases per million population per year. Due to the low incidence of ACC knowledge concerning the surgical management is mainly based on retrospective studies or recommendations of isolated experts. Cancer databases, such as the German ACC registry are prerequisite to collect and evaluate clinical data from a large number of patients. For non-metastatic tumor stages, complete tumor resection is the only treatment with curative intent. Open surgery remains the recommended approach for ACC. However, in small tumors with uncertain malignancy a laparoscopic resection by an expert surgeon can be considered. A loco-regional lymphadenectomy should be part of the primary surgical treatment of ACC. Tumor recurrence is common even after an apparently complete primary resection. Therefore, based on the individual risk (tumor size, resection status, proliferation index) adjuvant mitotane treatment is recommended in most patients. Patients with low-risk should be included in the ADIUVO trial. In case of tumor relapse indications for a reoperation should be strongly considered, especially when the time interval since the primary surgery is long (> 12 months) and a complete resection of the recurrent disease seems to be feasible.

PubMed Disclaimer

References

    1. Nat Rev Endocrinol. 2011 Jun;7(6):323-35 - PubMed
    1. Surgery. 2012 Jul;152(1):123-32 - PubMed
    1. J Clin Endocrinol Metab. 2006 Jun;91(6):2027-37 - PubMed
    1. Eur Urol. 2010 May;57(5):873-8 - PubMed
    1. Endocr Relat Cancer. 2007 Mar;14(1):13-28 - PubMed

MeSH terms

LinkOut - more resources